<p>Groups of ten BALB/c mice (3-week-old) were vaccinated with 5×10<sup>4</sup> PFU MVTT1, MVTT2 or MVTT3 via intramuscular routes. Mice received PBS were included as controls. Four weeks post-immunization, the mice were challenged intranasally with 500×LD<sub>50</sub> VTT strain. Cross marks indicate the mice that were killed because of a 30% weight loss. Data show average percent change in pre-challenge weigh. The error bar indicates the standard deviation (SD) of animals from each group.</p
<p>Six-day-old mice were inoculated SC with 5×10<sup>4</sup> PFU of VEEV TC-83 or IRES-based viruses...
<p>(A–C) Groups of 9 BALB/c mice were vaccinated with 10<sup>10</sup> vp/mouse of PAV3-HA (▵), AdHu5...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>C57BL/6 mice (○) or C57BL/6 mice depleted of CD4 and CD8 T cells (◊) were (A) vaccinated with 10<...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Mice (groups of 5) were mock-immunized with PBS or immunized with either 10<sup>3</sup> or 10<sup...
<p>Recipient mice received serum (A and B) CD4+T cells (C and D) or CD8+T cells (E and F) obtained f...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<div><p>(A) Three groups of mice were vaccinated with escalating doses of VV-hTAP1,2 (3e3 PFU, 3e4 P...
<p>Groups of 10 BALB/c mice were immunized i.m. with 2 µg sH5<sup>3</sup> either once (day 21) or tw...
<p>(A) Groups of mice (n = 10 each group) at day 1 after birth were intraperitoneally injected with ...
<p>Mice (n = 8) were vaccinated intranasally with Flu-NA-DIII (•) or Flu-NA-GFP (○) or by the subcut...
<p>Vaccinated and control mice were challenged with 2x10<sup>5</sup> PFU of MPXV 50 days following t...
<p>Survival rates (A, C) and body weight changes (B, D) of BALB/c mice after i.n. challenge with 20×...
<p>(A) Weight loss. Groups of 5 to 10 four-week-old C57BL/6 mice were infected intranasally with 10<...
<p>Six-day-old mice were inoculated SC with 5×10<sup>4</sup> PFU of VEEV TC-83 or IRES-based viruses...
<p>(A–C) Groups of 9 BALB/c mice were vaccinated with 10<sup>10</sup> vp/mouse of PAV3-HA (▵), AdHu5...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>C57BL/6 mice (○) or C57BL/6 mice depleted of CD4 and CD8 T cells (◊) were (A) vaccinated with 10<...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Mice (groups of 5) were mock-immunized with PBS or immunized with either 10<sup>3</sup> or 10<sup...
<p>Recipient mice received serum (A and B) CD4+T cells (C and D) or CD8+T cells (E and F) obtained f...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<div><p>(A) Three groups of mice were vaccinated with escalating doses of VV-hTAP1,2 (3e3 PFU, 3e4 P...
<p>Groups of 10 BALB/c mice were immunized i.m. with 2 µg sH5<sup>3</sup> either once (day 21) or tw...
<p>(A) Groups of mice (n = 10 each group) at day 1 after birth were intraperitoneally injected with ...
<p>Mice (n = 8) were vaccinated intranasally with Flu-NA-DIII (•) or Flu-NA-GFP (○) or by the subcut...
<p>Vaccinated and control mice were challenged with 2x10<sup>5</sup> PFU of MPXV 50 days following t...
<p>Survival rates (A, C) and body weight changes (B, D) of BALB/c mice after i.n. challenge with 20×...
<p>(A) Weight loss. Groups of 5 to 10 four-week-old C57BL/6 mice were infected intranasally with 10<...
<p>Six-day-old mice were inoculated SC with 5×10<sup>4</sup> PFU of VEEV TC-83 or IRES-based viruses...
<p>(A–C) Groups of 9 BALB/c mice were vaccinated with 10<sup>10</sup> vp/mouse of PAV3-HA (▵), AdHu5...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...